+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ventricular Assist Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • PDF Icon

    Report

  • 138 Pages
  • June 2023
  • Region: Global
  • IMARC Group
  • ID: 5547055

Quick Summary:

The global Ventricular Assist Devices (VAD) market signifies a critical domain in the medical appliances industry. The vital function of these mechanical circulatory support implements - facilitating the pumping of blood from the heart's chambers to the body - makes them indispensable in a host of therapeutic settings. Applicability ranges from short-term support post-surgery to the bridging period while awaiting heart transplantation.

The escalations in cardiovascular healthcare challenges like hypertension and heart failure continue to spearhead the demand for VADs. This surge is exacerbated by limited heart donor availability. Specifically, healthcare providers are pivoting towards the deployment of VADs to sustain blood circulation till heart implantation, effectively managing hospital mortality rates, duration of stay, and subsequent costs. Technological advancements are being incorporated to create miniaturized devices with infection control measures, addressing complications such as infection risk, thrombus formation, and blood trauma. Furthermore, clinical trials aim for better survival rates through enhancements in device durability, functionality, and efficiency. With comprehensive market segmentation and key player analysis, the global Ventricular Assist Devices market report presents an essential read to stay ahead in this vital industry.

The global ventricular assist devices market size reached US$ 1.7 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 9.7% during 2023-2028.

A ventricular assist device (VAD), also known as a mechanical circulatory support device, is a mechanical pump that transports blood from the lower chambers of the heart to the rest of the body. It generally comprises three components, which include tubes, an electronic controller and a power source. The tubes carry blood into the pump and transfer it into blood vessels, while the power source is connected to a control unit for monitoring the functions of the VAD. The device is implanted in patients as a short-term treatment for supporting heart functions after surgery or while they are waiting for a heart transplant. It finds application in the bridge-to-transplant (BTT), bridge-to-recovery (BTR), bridge-to-candidacy (BTC) and destination therapies.

The increasing cases of cardiovascular diseases, such as hypertension, ventricular septal defect, heart failure and stroke, represents one of the significant factors propelling the global VAD market growth. Moreover, the limited number of heart donors is escalating the demand for VADs across the globe. In order to overcome this shortage, healthcare providers are focusing on the utilization of VADs to keep the blood pumping until a new heart is implanted. This helps in reducing the hospital mortality rate, length of stay and overall hospital costs. Furthermore, the leading manufacturers in the industry are incorporating technological advancements, such as miniature devices with infection control technology, to address complications, such as the high risk of infection, thrombus formation and blood trauma. Apart from this, several clinical trials are being undertaken to improve the survival rate by enhancing the durability, functionality and efficiency of the devices.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global ventricular assist devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, flow type, product type, application and end-user.

Breakup by Product:

  • Left Ventricular Assist Device (LVAD)
  • Right Ventricular Assist Device (RVAD)
  • Biventricular Assist Device (BiVAD)
  • Others

Breakup by Flow Type:

  • Pulsatile Flow
  • Non-Pulsatile or Continuous Flow

Breakup by Product Type:

  • Implantable Ventricular Assist Devices
  • Non-implantable Ventricular Assist Devices

Breakup by Application:

  • Bridge-to-Transplant (BTT) Therapy
  • Destination Therapy
  • Bridge to Recovery and Bridge to Candidacy

Breakup by End-User:

  • Ambulatory Surgery Centers
  • Hospital
  • Others

Breakup by Region:

North America

  • United States
  • Canada

Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others

Latin America

  • Brazil
  • Mexico
  • Others

Middle East and Africa


Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Abiomed Inc., Berlin Heart GmbH (Syscore GmbH), Bivacor Inc., Calon Cardio, Cardiacassist Inc. (LivaNova PLC), CHF Solutions Inc., Jarvik Heart Inc., MAQUET GmbH (Getinge), Medtronic Inc., Syncardia Systems LLC (Versa Capital Management LLC), TandemLife (LivaNova PLC), Terumo Corporation, etc.

Key Questions Answered in This Report:

  • How has the global ventricular assist devices market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global ventricular assist devices market?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the flow type?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global ventricular assist devices market and who are the key players?
  • What is the degree of competition in the industry?
Frequently Asked Questions about the Global Ventricular Assist Devices Market

What is the estimated value of the Global Ventricular Assist Devices Market?

The Global Ventricular Assist Devices Market was estimated to be valued at $1.7 Billion in 2022.

What is the growth rate of the Global Ventricular Assist Devices Market?

The growth rate of the Global Ventricular Assist Devices Market is 10.5%, with an estimated value of $3.1 Billion by 2028.

What is the forecasted size of the Global Ventricular Assist Devices Market?

The Global Ventricular Assist Devices Market is estimated to be worth $3.1 Billion by 2028.

Who are the key companies in the Global Ventricular Assist Devices Market?

Key companies in the Global Ventricular Assist Devices Market include Abbott Laboratories, Abiomed Inc., Berlin Heart GmbH (Syscore GmbH), Bivacor Inc., Calon Cardio, Cardiacassist Inc. (LivaNova PLC), CHF Solutions Inc., Jarvik Heart Inc., MAQUET GmbH (Getinge) and Medtronic Inc..

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Ventricular Assist Device Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Left Ventricular Assist Device (LVAD)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Right Ventricular Assist Device (RVAD)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Biventricular Assist Device (BiVAD)
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Flow Type
7.1 Pulsatile Flow
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Non-Pulsatile or Continuous Flow
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Product Type
8.1 Implantable Ventricular Assist Devices
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Non-implantable Ventricular Assist Devices
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Application
9.1 Bridge-to-Transplant (BTT) Therapy
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Destination Therapy
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Bridge to Recovery and Bridge to Candidacy
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by End-User
10.1 Ambulatory Surgery Centers
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Hospitals
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Others
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Indicators
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Abbott Laboratories
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Abiomed Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Berlin Heart GmbH (Syscore GmbH)
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 Bivacor Inc.
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.5 Calon Cardio
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.6 Cardiacassist Inc. (LivaNova PLC)
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 CHF Solutions Inc.
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.8 Jarvik Heart Inc.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.9 MAQUET GmbH (Getinge)
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Medtronic Inc.
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Syncardia Systems LLC (Versa Capital Management LLC)
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 SWOT Analysis
16.3.12 TandemLife (LivaNova Plc)
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.13 Terumo Corporation
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.13.3 Financials
16.3.13.4 SWOT Analysis
List of Figures
Figure 1: Global: Ventricular Assist Device Market: Major Drivers and Challenges
Figure 2: Global: Ventricular Assist Device Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Ventricular Assist Device Market: Breakup by Product (in %), 2022
Figure 4: Global: Ventricular Assist Device Market: Breakup by Flow Type (in %), 2022
Figure 5: Global: Ventricular Assist Device Market: Breakup by Product Type (in %), 2022
Figure 6: Global: Ventricular Assist Device Market: Breakup by Application (in %), 2022
Figure 7: Global: Ventricular Assist Device Market: Breakup by End-User (in %), 2022
Figure 8: Global: Ventricular Assist Device Market: Breakup by Region (in %), 2022
Figure 9: Global: Ventricular Assist Device Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 10: Global: Ventricular Assist Device (Left Ventricular Assist Device) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Ventricular Assist Device (Left Ventricular Assist Device) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Ventricular Assist Device (Right Ventricular Assist Device) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Ventricular Assist Device (Right Ventricular Assist Device) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Ventricular Assist Device (Biventricular Assist Device) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Ventricular Assist Device (Biventricular Assist Device) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Ventricular Assist Device (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Ventricular Assist Device (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Ventricular Assist Device (Pulsatile Flow) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Ventricular Assist Device (Pulsatile Flow) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Ventricular Assist Device (Non-Pulsatile or Continuous Flow) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Ventricular Assist Device (Non-Pulsatile or Continuous Flow) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Ventricular Assist Device (Implantable Ventricular Assist Devices) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Ventricular Assist Device (Implantable Ventricular Assist Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Ventricular Assist Device (Non-implantable Ventricular Assist Devices) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Ventricular Assist Device (Non-implantable Ventricular Assist Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Ventricular Assist Device (Bridge-to-Transplant Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Ventricular Assist Device (Bridge-to-Transplant Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Ventricular Assist Device (Destination Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Ventricular Assist Device (Destination Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Ventricular Assist Device (Bridge to Recovery and Bridge to Candidacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Ventricular Assist Device (Bridge to Recovery and Bridge to Candidacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Ventricular Assist Device (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Ventricular Assist Device (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Ventricular Assist Device (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Ventricular Assist Device (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Ventricular Assist Device (Other End-Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Ventricular Assist Device (Other End-Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: North America: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: North America: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: United States: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: United States: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Canada: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Canada: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Asia Pacific: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Asia Pacific: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: China: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: China: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Japan: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Japan: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: India: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: India: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: South Korea: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: South Korea: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Australia: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Australia: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Indonesia: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Indonesia: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Others: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Europe: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Europe: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Germany: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Germany: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: France: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: France: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: United Kingdom: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: United Kingdom: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Italy: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Italy: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Spain: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Spain: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Russia: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Russia: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Others: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Latin America: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Latin America: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Brazil: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Brazil: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Mexico: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Mexico: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Others: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Middle East and Africa: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Middle East and Africa: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Global: Ventricular Assist Device Industry: SWOT Analysis
Figure 87: Global: Ventricular Assist Device Industry: Value Chain Analysis
Figure 88: Global: Ventricular Assist Device Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Ventricular Assist Device Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Ventricular Assist Device Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Ventricular Assist Device Market Forecast: Breakup by Flow Type (in Million US$), 2023-2028
Table 4: Global: Ventricular Assist Device Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
Table 5: Global: Ventricular Assist Device Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 6: Global: Ventricular Assist Device Market Forecast: Breakup by End-User (in Million US$), 2023-2028
Table 7: Global: Ventricular Assist Device Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 8: Global: Ventricular Assist Device Market Structure
Table 9: Global: Ventricular Assist Device Market: Key Players

Companies Mentioned

  • Abbott Laboratories
  • Abiomed Inc.
  • Berlin Heart GmbH (Syscore GmbH)
  • Bivacor Inc.
  • Calon Cardio
  • Cardiacassist Inc. (LivaNova PLC)
  • CHF Solutions Inc.
  • Jarvik Heart Inc.
  • MAQUET GmbH (Getinge)
  • Medtronic Inc.
  • Syncardia Systems LLC (Versa Capital Management LLC)
  • TandemLife (LivaNova PLC)
  • Terumo Corporation

Methodology

Loading
LOADING...